Clin Osteol 2024; 29(4): 151-156

COVID-19 treatment and glucocorticoid-induced osteoporosis: a case reportCase reports

Štambera Dalibor
Kardiologická a osteologická ambulance, Kardio Znojmo s. r. o

This case report describes the case of a patient treated with glucocorticoids in connection with his COVID-19 disease, who was subsequently diagnosed with glucocorticoid-induced osteoporosis (GIOP), the most common type of secondary osteoporosis today, based on densitometric findings and a history of low-strain fracture. The article highlights the need for preventive vitamin D and calcium supplementation during glucocorticoid treatment and also the need to perform whole-body densitometry at prescribed intervals in accordance with relevant recommendations.

Keywords: calcium (Ca); COVID-19; densitometry; glucocorticoids; glucocorticoid-induced osteo-porosis (GIOP); supplementation; vitamin D

Published: December 11, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štambera D. COVID-19 treatment and glucocorticoid-induced osteoporosis: a case report. Clinical Osteology. 2024;29(4):151-156.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Trojánek M, Grebenyuk V, Herrmannová K et al. Nový koronavirus (SARS-CoV-2) a onemocnění COVID-19. Nedatováno. Dostupné z WWW: <https://infektologie.cz/Covid2019/Covid19-CLC20.pdf>.
    2. Štefan M, Chrdle A, Husa P et al. COVID-19: diagnostika a léčba. Nedatováno. Dostupné z WWW: <https://infektologie.cz/DPCovid21/DP5-covid-DP-podrobny-10-22.pdf>.
    3. OECD. The impact of COVID-19 on health and health systems -⁠ OECD [24-06 -⁠ 2024]. Dostupné z WWW: <https://www.oecd.org/health/COVID-19.htm>.
    4. NHS. COVID-19-healthcare-delivery-impacts-quick-sheet.pdf. [24-06-2024]. Dostupné z WWW: <https://files.asprtracie.hhs.gov/documents/COVID-19-healthcaredelivery-impacts-quick-sheet.pdf>.
    5. Čechům se během pandemie zhoršil zdravotní stav, odkládali návštěvu lékaře. Ministerstvo zdravotnictví. [24-06-2024]. Dostupné z WWW: <https://mzd.gov.cz/tiskove-centrum-mz/cechum-se-behem-pandemie-zhorsilzdravotni-stav-odkladali-navstevu-lekare/>.
    6. Džupa V a Jenšovský J ed. Diagnostika a léčba osteoporózy a dalších onemocnění skeletu. Karolinum: Praha 2018. ISBN 978-80-246-3761-7.
    7. Pikner R, Palička V, Vyskocil V et al. Definice osteoporotické (křehké) zlomeniny: stanovisko Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně (SMOS ČLS JEP). Clin Osteol 2020; 25(2): 83-84.
    8. Willers C, Norton N, Harvey NC et al. [The Scope Review Panel of the IOF]. Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteopor 2022; 17(1): 1-129. Dostupné z DOI: <http://dx.doi.org/10.1007/s11657-021-00969-8>. Go to original source...
    9. Kanis JA, Cooper C, Rizzoli R et al. [Scientific advisory board of the European Society for Clinical and Economic aspects of Osteoporosis (ESCEO) and the committees of scientific advisors and national societies of the International Osteoporosis Foundation (IOF)]. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteopor Int 2019; 30(1): 3-44. Dostupné z DOI: http://dx.doi.org/10.1007/s00198-018-4704-5> Go to original source...
    10. Harris K, Zagar CA, Lawrence KV. Osteoporosis: Common Questions and Answers. Am Fam Physician 2023; 107(3): 238-246.
    11. Humphrey MB, Russell L, Danila MI et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 2023; 75(12): 2088-2102. Dostupné z DOI: <http://dx.doi.org/10.1002/art.42646>. Go to original source...
    12. Zikán V. Glukokortikoidy Indukovaná osteoporóza. Interni Med 2007; 9(7-8): 324-327.
    13. Evenity. Souhrn údajů o přípravku. Dostupné z WWW: <https://www.ema.europa.eu/cs/documents/product-information/evenity-epar-productinformation_cs.pdf>.
    14. Teriparatid -⁠ SÚKL ceny a úhrady. SÚKL -⁠ Přehled léčiv. [24-06-2024]. Dostupné z WWW: <https://prehledy.sukl.cz/prehled_leciv.html#/leciva/0025491>.
    15. Gregson C, Armstrong DJ, Bowden J et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 2022; 17(1): 58. Dostupné z DOI: <http://dx.doi.org/10.1007/s11657-022-01061-5>. Go to original source...
    16. Leboff MS, Greenspan SL, Insogna KL et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2022; 33(10): 2049-2102. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198-021-05900-y>. Go to original source...
    17. Bayer M, Pavel Horák P, Palička V et al. Dlouhodobá léčba osteoporózy denosumabem a její přerušení: odborné stanovisko pracovní skupiny Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně. Clin Osteol 2018; 23(1): 32-37.

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.